Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,105,793
-
Share change
-
+7,428,672
-
Total reported value
-
$2,396,333,243
-
Price per share
-
$64.59
-
Number of holders
-
156
-
Value change
-
+$485,399,159
-
Number of buys
-
110
-
Number of sells
-
37
Institutional Holders of TURNING POINT THERAPEUTICS I - COM (TPTX) as of Q2 2020
As of 30 Jun 2020,
TURNING POINT THERAPEUTICS I - COM (TPTX) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,105,793 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, Cormorant Asset Management, LP, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, PICTET ASSET MANAGEMENT LTD, and ALLIANCEBERNSTEIN L.P..
This page lists
156
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.